China regulator approves Blackstone, TPG acquisition of medtech firm Hologic

TPG

10/02/2026 01:16

BEIJING, Feb 10 (Reuters) - China has approved private equity firms Blackstone BX.N and TPG's TPG.O acquisition of medical diagnostics firm Hologic HOLX.O, according to a list of deal approvals from the country's market regulator released on Tuesday.

Hologic, which develops and distributes medical imaging and diagnostic products for women's healthcare, has manufacturing operations and a partnership in China.

The State Administration for Market Regulation did not detail whether the approval was for the acquisition of specific Hologic China-based units.

The regulator has jurisdiction over foreign companies with substantial business or sales in China.

Blackstone and TPG announced in October they would take Hologic private for $18.3 billion including debt, in the largest medical devices deal in almost two decades.

 (Reporting by Liz Lee and Shi Bu; Editing by Christopher Cushing)

 ((liz.lee@thomsonreuters.com))